Celegence adds report writing functionality to EU MDR & IVDR compliance technology CAPTIS™ to help streamline medical writing and document maintenance

Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the addition of new features to CAPTIS™ to help the device and diagnostic industry produce compliant Post Market Surveillance (PMS) documentation more efficiently.

Analytical Standards Market Size, Technique, and Forecast to 2028

Global analytical standards market is analysed based on product, technique, methodology, category and geography.

CloudLIMS Exhibits its Secure Medical and Healthcare LIMS @ 2022 AACC, Chicago

CloudLIMS is exhibiting @2022 AACC Annual Scientific Meeting & Clinical Lab Expo and showcasing its Medical & Healthcare LIMS at Booth 464 from July 26 - 28 in Chicago.

WHO calls for new innovations to tackle antimicrobial resistance crisis

With only a few antibiotics in clinical development, new technologies, especially ones that do not develop antimicrobial resistance, are needed to treat healthcare-associated infections. An innovation from UCL in London and developed by Canadian life sciences company, Ondine Biomedical, uses photodisinfection to kill infection-causing pathogens, including viruses, bacteria, and fungi.

DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400

DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose

CD Formulation Enlarges Particulate Matter Testing Capability

A Comprehensive Portfolio of Hydrophobic Polymers Makes Breakthroughs Closer

3D Bioprinting Market Owing To Growth Within Biotechnology Sector from 2019 to 2028

The global 3D bioprinting market is segmented based on technology, material, application and geography. Based on technology, the market is categorized into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting and microextrusion 3D bioprinting.

BOC Sciences Highlighted Carbohydrates Harvest Admiring Fans at CPhI North America 2022

BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 

BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production

BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D

BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies

CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service

Innovative Impurity Isolation and Identification Techniques at BOC Sciences to Address Pharmaceutical Impurity Issues

BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.

NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

MultiOmic Health and Mesh Bio partner to use AI to develop precision medicines and diagnostics for chronic metabolic disease

MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease. The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.

Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies

Saama Technologies Announces Appointment of New CEO Vivek Sharma

#1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO